• Trending
  • Latest
    Sign in Sign up

    • Log In
    • Register
    • Home
    • Discover
    • Experts
    • Home
    • Discover
    • Experts
    • Learning Lab
    • Home
    • Discover
    • Experts
    • Learning Lab
    • Mashup Score: 0
      Oura, Maven Clinic team up to bring biometric data into clinical care - 11 minute(s) ago

      The health insights tracked by Oura Ring will be utilized by Maven Clinic’s doctors and care teams as part of a new partnership.

      Source: www.cnbc.com
      Categories: General Medicine News
      Tweet Tweets with this article
      • Profile photo of 	EvanKirstel
        EvanKirstel

        The health insights tracked by Oura Ring will be utilized by Maven Clinic's doctors and care teams as part of a new partnership. Source: CNBC https://t.co/u6xrsgWItk

    • Mashup Score: 0
      The Directors: Candace Johnson and Jonathan Friedberg on living through uncertainty at NCI, payment woes Directors of two neighboring cancer centers in Upstate New York will face challenges, but “we’ll get through it” - The Cancer Letter - 12 minute(s) ago

      Candace S. Johnson leads America’s oldest cancer research center and Jonathan W. Friedberg leads the newest NCI-designated center. Their catchment areas are contiguous, their faculty and staff members collaborate often, and together their institutions embody the culture of NCI-designated cancer centers.  Johnson and Friedberg appear on The Directors, a monthly series on The Cancer Letter […]

      Source: cancerletter.com
      Categories: General Medicine News
      Tweet Tweets with this article
      • Profile photo of 	TheCancerLetter
        TheCancerLetter

        Candace S. Johnson leads America’s oldest cancer research center and Jonathan W. Friedberg leads the newest NCI-designated center. What worries them the most? It’s a combination of threats coming from Washington.   https://t.co/rOl2qwicJ4 https://t.co/2Byic4qxnD

    • Mashup Score: 1
      Next-Generation Obesity Treatments Take Center Stage at ADA - 12 minute(s) ago

      Research symposia focus on new combinations and medication formulations for both obesity and type 2 diabetes, as well as new approaches for type 1 diabetes and much more.

      Source: www.medscape.com
      Categories: General Medicine News
      Tweet Tweets with this article
      • Profile photo of 	Medscape
        Medscape

        The upcoming American Diabetes Association (ADA) 85th Scientific Sessions will focus on new and evolving weight-loss treatments for people with and without diabetes, along with new biological and technological approaches for managing type 1 diabetes (T1D). https://t.co/pSrVz5fEMN https://t.co/uWmSllvpBj

    • Mashup Score: 1
      ISAKOS PODCAST • A podcast on Spotify for Creators - 12 minute(s) ago

      Official Podcast for the International Society of Arthroscopy, Knee Surgery and Orthopaedic Sports Medicine

      Source: creators.spotify.com
      Categories: General Medicine News
      Tweet Tweets with this article
      • Profile photo of 	J_ISAKOS
        J_ISAKOS

        In our latest #JISAKOSInFocus, Dr. @VolkerMusahl and Dr. @JonathanDHughe1 take us behind the scenes of the legendary Panther Meeting — a gathering of the world’s top knee and ACL experts. 🎧 Listen Here: https://t.co/I3iJTRxrKy 📖 Read the Article: https://t.co/WETlwU8hX4 https://t.co/740GECoFiW

    • Mashup Score: 1
      The Medical Sisterhood—The Global Sisterhood: When She Speaks the World Listens - 12 minute(s) ago

      Melinda Gooderham, MD, MSc, joins The Medical Sisterhood to discuss balancing mentorship, leadership, and family, as well as the empowerment of women in the medical field.

      Source: www.hcplive.com
      Categories: General Medicine News
      Tweet Tweets with this article
      • Profile photo of 	MDMagazine
        MDMagazine

        🚨NEW:🚨 The latest episode of #TheMedicalSisterhood podcast🎙️ is out now! Dr. Melinda Gooderham of @SKiNDermatology spoke with Dr. Mona Shahriari about imposter syndrome, confidence, improving public speaking, and balancing life & career. 🔗https://t.co/j89rvb43hU https://t.co/e2auwGgyOE

    • Mashup Score: 0
      Patritumab Deruxtecan Does Not Improve Overall Survival in EGFR-Mutated NSCLC - 12 minute(s) ago

      Patritumab deruxtecan did not improve OS vs platinum-based chemotherapy in patients with EGFR mutation–positive locally advanced or metastatic NSCLC.

      Source: www.onclive.com
      Categories: General Medicine News
      Tweet Tweets with this article
      • Profile photo of 	OncLive
        OncLive

        The ADC patritumab deruxtecan did not improve OS vs platinum-based chemotherapy in patients with EGFR mutant, locally advanced or metastatic #NSCLC. @ASCO #ASCO25 #LCSM Read up on the HERTHENA-Lung02 trial here: https://t.co/5R1rwQbgVT

    • Mashup Score: 3487
      WE HIT A 5000X+ WIN on ULTIMATE SLOT OF AMERICA! (INSANE SET UP) - 16 minute(s) ago

      i was not expecting this out of nowhere..My twitter: https://x.com/JuicyFruityyyMy kick: https://kick.com/juicyliveTHIS VIDEO INCLUDES PAID PROMOPLEASE DO YO…

      Source: www.youtube.com
      Categories: General Medicine News, Rheumatology
      Tweet Tweets with this article
      • Profile photo of 	HsiehEvelyn
        HsiehEvelyn

        RT @JuicyFruityyy: $1000 ROOBET FREE SPINS GIVEAWAY! To Enter: -RT this tweet -Like this video: (show proof) https://t.co/neVPSTNYBp -com…

    • Mashup Score: 0
      Safety in a hybrid hospital‐at‐home program versus traditional inpatient care: A pragmatic randomized controlled trial - 21 minute(s) ago

      Background Hospital-at-home programs (HaH) in the United States have evolved to include a virtual-hybrid delivery model, where all physician encounters are virtual and partnered with a home care tea…

      Source: shmpublications.onlinelibrary.wiley.com
      Categories: General Medicine News
      Tweet Tweets with this article
      • Profile photo of 	hemant_murthy
        hemant_murthy

        Safety in a hybrid hospital‐at‐home program versus traditional inpatient care: A pragmatic randomized controlled trial - Maniaci - Journal of Hospital Medicine - Wiley Online Library @MayoClinic https://t.co/KsSCv23pXq

    • Mashup Score: 2
      Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial - 31 minute(s) ago

      In patients with resistant hypertension, aprocitentan was well tolerated and superior to placebo in lowering blood pressure at week 4 with a sustained effect at week 40.

      Source: www.thelancet.com
      Categories: General Medicine News, Nephrology
      Tweet Tweets with this article
      • Profile photo of

        PRECISION: In patients w/ resistant hypertension, aprocitentan was well tolerated & superior to placebo in lowering BP at week 4 w/ a sustained effect at week 40 ca. 2022 from @TheLancet #Nephpearls #VisualAbstract by @Sandyrvsdav 👉🏼 https://t.co/qs5lYNUDX1 https://t.co/ZP5KbUWsNM

    • Mashup Score: 3
      A developer’s guide to AI protocols: MCP, A2A, and ACP - 32 minute(s) ago

      Model Context Protocol, Agent2Agent protocol, and Agent Communication Protocol take slightly different approaches to AI agent communications. Let’s unpack them.

      Source: www.infoworld.com
      Categories: General Medicine News
      Tweet Tweets with this article
      • Profile photo of 	EvanKirstel
        EvanKirstel

        Model Context Protocol, Agent2Agent protocol, and Agent Communication Protocol take slightly different approaches to AI agent communications. Let’s unpack them.… Source: InfoWorld https://t.co/08N6Yp1YEv

    Load More
    ASCO 2025

    Advertisement

    Advertisement

    MashupMD
    © 2025 - Mashup Media LLC
    • Terms of Use
    • Privacy Policy
    • Cookie Settings